Estradiol metabolism: An endocrine biomarker for modulation of human mammary carcinogenesis

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 3, 1997, Pages 559-564

  Telang, Nitin T ^a   Katdare, Meena ^a   Bradlow, H Leon ^a   Osborne, Michael P ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Chemoprevention; Estrogen metabolites; In vitro models; Mammary carcinogenesis

Indexed keywords

3 INDOLEMETHANOL; 7,12 DIMETHYLBENZ[A]ANTHRACENE; BENZO[A]PYRENE; ESTRADIOL;

APOPTOSIS; BREAST CARCINOGENESIS; CELL CULTURE; CELL METABOLISM; CONFERENCE PAPER; DNA SYNTHESIS; HORMONE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MODEL; PRIORITY JOURNAL; TISSUE CULTURE;

RODENTIA; TRITIUM;

EID: 0030911796     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s3559     Document Type: Conference Paper

References (45)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 65:5-27 (1996).
2. Russo J, Calaf G, Sohi N, Tahin Q, Zhang PL, Alvarado ME, Estrado S, Russo IH. Critical steps in breast carcinogenesis. Ann NY Acad Sci 698:1-20 (1993).
3. Welsch CW. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45:3415-3443 (1985).
4. Telang NT, Bradlow HL, Osborne MP. Molecular and endocrine biomarkers in noninvolved breast: relevance to cancer chemoprevention. J Cell Biochem 16G:161-169 (1992).
5. Henderson BE, Ross RK, Pike MC. Toward the primary prevention of breast cancer. Science 254:1131-1138 (1991).
6. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation and breast cancer risk. Epidemiol Rev 15:17-35 (1993).
7. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 15:48-65 (1993).
8. Howell AE, Anderson E, Laidlaw I. Cyclical activity and 'aging of the human breast: clues to assessment of risk and strategies for prevention. In: Endocrine Therapy of Breast Cancer (Howell A, ed). New York:Springer-Verlag, 1994;27-46.
9. Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Doody LA, Greenwald P. Development of breast cancer chemopreventive drugs. J Cell Biochem 17G:2-13 (1993).
10. Welsch CW. Rodent models to examine in vivo hormonal regulation of mammary gland tumorigenesis. In: Cellular and Molecular Biology of Mammary Cancer (Medina D, Kidwell W, Hepner G, eds). New York:Plenum Press 1987;163-179.
11. Nandi S, Guzman RC, Yang J. Hormones and mammary carcinogenesis in mice, rats and humans: a unifying hypothesis. Proc Nad Acad Sci USA 92:3650-3657 (1995).
12. Sekeris CE. Hormonal steroids act as tumor promoters by modulating oncogene expression. J Cancer Res Clin Oncol 117:96-101 (1991).
13. Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther 57:237-257 (1993).
14. Adams JB. Enzymatic regulation of estradiol 17-β concentrations in human breast cancer cells. Breast Cancer Res Treat 20:145-154 (1992).
15. Weisz A, Bresciani F. Estrogen regulation of protooncogenes coding for nuclear proteins. Crit Rev Oncol 4:361-388 (1993).
16. Dubik D, Shiu RPC. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7:1587-1594 (1992).
17. Telang, NT, Kurihara H, Wong GYC, Bradlow HL, Osborne MP. Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention. Anticancer Res 11:1021-1028 (1991).
18. Garg A, Suto A, Osborne MP, Gupta RC, Telang NT. Expression of biomarkers of transformation in 7,12-dimethylbenz(a)anthracene-treated mammary epithelial cells. Int J Oncol 3:105-109 (1993).
19. Telang NT, Narayanan R, Bradlow HL, Osborne MP. Coordinated expression of intermediate biomarkers for tumorigenic transformation in Ras-transfected mouse mammary epithelial cells. Breast Cancer Res Treat 18:155-163 (1991).
20. Fishman J, Osborne MP, Telang NT. The role of estrogen in mammary carcinogenesis. Ann NY Acad Sci 768:91-100 (1995).
21. Telang NT. Oncogenes, estradiol biotransformation and mammary carcinogenesis. Ann NY Acad Sci 784:277-287 (1996).
22. Osborne MP, Bradlow HL, Wong GYC, Telang NT. Upregulation of estradiol C16α-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J Natl Cancer Inst 85:1917-1920 (1993).
23. Telang NT, Axelrod DM, Wong GYC, Bradlow HL, Osborne MP. Biotransformation of estradiol by explant cultures of human mammary tissue. Steroids 56:37-43 (1991).
24. Stampfer MR, Bartley JC. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc Natl Acad Sci USA 82:2394-2398 (1985).
25. Zhai YF, Beittenmiller H, Wang BC, Gould MN, Oakley C, Esselman WJ, Welsch CW. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res 53:2272-2278 (1993).
26. McCormick DB, Burns FJ, Albert RE. Inhibition of benzo[a]pyrene-induced mammary carcinogenesis by retinyl acetate. J Natl Cancer Inst 66:559-564 (1981).
27. Bradlow HL, Michnovicz JJ, Telang NT, Osborne MP. Effect of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumorigenesis in mice. Carcinogenesis 12:1571-1574 (1991).
28. Kojima T, Tanaka T, Mori H. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 54:1446-1449 (1994).
29. Sepkovic DW, Bradlow HL, Michnovicz J, Murtezani S, Levy I, Osborne MP. Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or β-napthaflavone: a comparison of stable isotope dilution, GC-MS and radiometric methods. Steroids 59:318-323 (1994).
30. Goldberg Y, Nassif II, Pittas A, Tsai LL, Dynlacht BD, Rigas B, Schiff SJ. The antiproliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle regulatory proteins. Oncogene 12:893-901 (1996).
31. Suto A, Bradlow HL, Wong GYC, Osborne MP, Telang NT. Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Res Treat 27:193-202 (1993).
32. Telang NT, Suto A, Wong GYC, Osborne MP, Bradlow, HL. Induction by estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 84:634-638 (1992).
33. Moore CJ, Tricomi WA, Gould MN. Interspecies comparison of benzo[a]pyrene and 7,12dimethylbenz[a]anthracene binding to nuclear macromolecules in human and rat mammary epithelial cells. Cancer Res 46:4946-4952 (1986).
34. Moore CJ, Eldrigdge SR, Tricomi WR, Gould MN. Quantitation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene binding to nuclear macromolecules in human and rat mammary epithelial cells. Cancer Res 47:2609-2613 (1987).
35. Stampfer MR, Bartholomew JC, Smith HS, Bartley JC. Metabolism of benzo[a]pyrene by human mammary epithelial cells: toxicity and DNA adduct formation. Proc Natl Acad Sci USA 78:6251-6255 (1981).
36. Mauvais-Jarvis P, Kuttenn F, Gompel A. Estradiol/progesterone interaction in normal and pathologic breast cells. Ann NY Acad Sci 464:152-167 (1986).
37. Zhu BT, Bui QD, Weisz H, Liehr JG. Conversion of estrone to 2- and 4-hydroxyestrone by hamster kidney and liver microsomes: implication for the mechanisms of estrogen induced carcinogenesis. Endocrinology 135: 1772-1779 (1994).
38. Li JJ, Li SA. Estrogen carcinogenesis in hamster tissues: a critical review. Endocr Rev 11:524-531 (1990).
39. Lottering ML, Haag M, Seegers JC. Effects of 17β-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res 52:5926-5932 (1992).
40. Schneider J, Huh MM, Bradlow HL, Fishman J. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 259:4840-4845 (1984).
41. Vandewalle B, Lefebre J. Opposite effects of estrogen and catechol estrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol Cell Endocrinol 61:239-246 (1989).
42. Tiwari RK, Li G, Bradlow HL, Telang NT, Osborne MP. Selective responsiveness of human breast cancer cells to indole3-carbinol, a chemopreventive agent. J Natl Cancer Inst 86:126-131 (1994).
43. Michnovicz JJ, Bradlow HL. Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J Natl Cancer Inst 50:947-950 (1990).
44. Bradlow HL, Sepkovic DW, Telang NT, Osborne MP. Indole3-carbinol: a novel approach for breast cancer prevention. Ann NY Acad Sci 768:180-200 (1995).
45. Davis D, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377 (1993).